Investigating the Role of Gut Microbiota Secondary Metabolism in IBD – a Path to Novel IBD Therapeutics.

Exploring The Therapeutic Potential Of MUC2, A Gut-Specific Mucin With Anti-Inflammatory Properties.

Epithelial Fucosylation, Microbiota and Inflammatory Bowel Disease.

Novel Adhesive Interactions Modulate T Cell Responses In IBD.

From Newborn Immunity To Adult IBD.

The Role Of Long Non-Coding RNA, LincRNA-Eps In Controlling Gut Inflammation.

Dysbiotic Intervention: Harnessing Intrinsic Human Defenses Via The Paneth Cell Secretome To Engineer The Microbiome.

Sensing Luminal Contents By The Enteric Nervous System: Consequences For Gut Immunity.

Control of Innate Lymphoid Cells and Intestinal Homeostasis by Neurotrophic Factors.

Investigating the Role of Gut Microbiota Secondary Metabolism in IBD – a Path to Novel IBD Therapeutics.